Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Spica Therapeutics

Request full access

Biotech innovator transforming macrophage biology into breakthrough therapies for oncology and fibroinflammatory diseases

Antwerp, BelgiumFounded 2022Biotech & Life Sciences

About Spica Therapeutics

Spica Therapeutics is a pioneering biotech company focused on transforming macrophage biology into breakthrough therapies. The company operates in the healthcare sector, specifically targeting oncology and fibroinflammatory diseases. Utilizing a proprietary platform, Spica Therapeutics employs functional macrophage fingerprinting technology to identify and target pathogenic macrophage subsets. This approach aims to improve patient outcomes by modulating macrophages. The company is advancing two lead programs, leveraging the Bioqube venture creation model to develop a robust pipeline of therapies. Headquartered in Belgium with operations in Denmark, Spica Therapeutics is built on a foundation of groundbreaking research published in highly ranked journals. The business model revolves around developing and commercializing therapies that address unmet medical needs, thereby generating revenue through partnerships and product sales.

Source: Dealroom company data

At a glance

Status
Operational
Employees
16
Open positions
None listed
Dealroom signal
66.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Aug 2025 $1.1M — VLAIO- Team Bedrijfstrajecten Crossroads France-Wallonie-Vlaanderen ↗
SEEDOther financing Jun 2025 $11M $44M PMV · Qbic Fund · Bioqube Ventures ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Spica Therapeutics website traffic

Latest recorded traffic for Spica Therapeutics is 30 monthly website visits, down 98.2% over the last three months.

Latest monthly visits30 3-month web change-98.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Spica Therapeutics in the Antwerp ecosystem

Live from Dealroom

The Spica Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • PMV
  • Bioqube Ventures
  • Qbic Fund
  • VLAIO- Team Bedrijfstrajecten Crossroads France-Wallonie-Vlaanderen

Other known investors1 additional known investor

  • Flanders Institute for Biotechnology
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇧🇪 Belgium57.1%
🇩🇰 Denmark42.9%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Spica Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Spica Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.